Balchem Corporation (BCPC)
| Market Cap | 4.87B |
| Revenue (ttm) | 1.01B |
| Net Income (ttm) | 149.20M |
| Shares Out | 32.39M |
| EPS (ttm) | 4.57 |
| PE Ratio | 32.94 |
| Forward PE | 27.72 |
| Dividend | $0.87 (0.57%) |
| Ex-Dividend Date | Dec 26, 2024 |
| Volume | 179,963 |
| Open | 153.00 |
| Previous Close | 153.35 |
| Day's Range | 150.40 - 155.16 |
| 52-Week Range | 139.17 - 180.66 |
| Beta | 0.99 |
| Analysts | Buy |
| Price Target | 176.00 (+16.98%) |
| Earnings Date | Oct 21, 2025 |
About BCPC
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipi... [Read more]
Financial Performance
In 2024, Balchem's revenue was $953.68 million, an increase of 3.39% compared to the previous year's $922.44 million. Earnings were $128.48 million, an increase of 18.36%.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for BCPC stock is "Buy." The 12-month stock price target is $176.0, which is an increase of 16.98% from the latest price.
News
Balchem Corporation to Present at Baird's 55th Annual Global Industrial Conference on November 12, 2025
MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird'...
Balchem: Bullish On Q3 Outperformance And Favorable Outlook (Upgrade)
I raise my rating for Balchem from "Hold" to "Buy," following my assessment of its performance and prospects. BCPC's 3Q2025 financials exceeded expectations, thanks to the strong showing from its Huma...
Balchem Corporation (BCPC) Q3 2025 Earnings Call Transcript
Balchem Corporation (NASDAQ:BCPC) Q3 2025 Earnings Call October 21, 2025 11:00 AM EDT Company Participants Carl Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore H...
Why Balchem Stock Jumped Today
Balchem reported record third-quarter sales. The company is growing sales while also supporting new growth initiatives.
Scoring Big With Fans: Balchem Spotlights the Power of Vitamin K2 at FC Bayern Women's Season Opener
MONTVALE, N. J.--(BUSINESS WIRE)--Balchem, a global manufacturer of specialty ingredients for human nutrition, has launched its first direct-to-consumer initiative.
Balchem Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025
MONTVALE, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the H....
Balchem (BCPC) Q2 EPS Jumps 16.5%
Balchem (BCPC 0.24%), a leading provider of nutritional ingredients and specialty chemicals, released its second quarter results on July 31, 2025. The key news: Balchem reported record GAAP revenue an...
Balchem Corporation (BCPC) Q2 2025 Earnings Call Transcript
Balchem Corporation (NASDAQ:BCPC) Q2 2025 Earnings Conference Call July 31, 2025 11:00 AM ET Company Participants Carl Martin Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Hea...
Balchem Corporation Reports Second Quarter 2025 Financial Results
MONTVALE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal second quarter ended June 30, 2025.
Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025
MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to re...
Balchem Corporation: The Next Earnings Release Should Guide Investors
Balchem operates in diverse specialty ingredient markets, maintaining steady growth and a market cap of $5.3B. Revenue per share has grown 6% annually over a decade, but recent growth has plateaued, w...
Balchem Corporation to Present at the CJS Annual New Ideas Summer Conference on July 10, 2025
MONTVALE, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJ...
Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025
MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wel...
Balchem Corporation to Participate in the dbAccess Global Consumer Conference on June 4, 2025
MONTVALE, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the...
Balchem Corporation (BCPC) Q1 2025 Earnings Call Transcript
Balchem Corporation (NASDAQ:BCPC) Q1 2025 Earnings Conference Call April 24, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President & CEO Conference Call Partic...
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025
MONTVALE, N.J., April 11, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, April 24, 2025, at 11:00 AM Eastern Time (ET) to ...
Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025
MONTVALE, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in th...
Balchem Is A Great Company, But I'm Still Waiting For A Better Entry
Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw mode...
Balchem Corporation (BCPC) Q4 2024 Earnings Conference Call Transcript
Balchem Corporation (NASDAQ:BCPC) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call P...
Balchem Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
MONTVALE, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal fourth quarter ended December 31, 2024.
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2024 Financial Results on February 21, 2025
MONTVALE, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 21, 2025, at 11:00 AM Eastern Time (ET) to ...
Balchem Corporation to Present at CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025
MONTVALE, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at CJS Se...
Balchem Corporation Announces Dividend
MONTVALE, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 9, 2024, its Board of Directors declared a dividend on its shares of common stock ...
Balchem Corporation to Present at Baird's 54th Annual Global Industrial Conference on November 13, 2024
MONTVALE, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird'...
Balchem's Q3 Shows Record Earnings And Valuation Pressure
Balchem Corporation shows strong long-term growth potential in high-margin segments and product innovation, but faces challenges in Animal Nutrition & Health and rising costs. Balchem's financial mome...